Pathfinder Cell Company Top Management
PFND Stock | USD 0.0001 0.00 0.00% |
Pathfinder Cell employs about 1 people. The company is managed by 3 executives with a total tenure of roughly 42 years, averaging almost 14.0 years of service per executive, having 0.33 employees per reported executive. Evaluation of Pathfinder Cell's management performance can provide insight into the firm performance.
Richard Franklin CEO President CEO, Secretary, Director |
Joerg Gruber Chairman Founder and Chairman |
Pathfinder |
Pathfinder Cell Management Team Effectiveness
The company has return on total asset (ROA) of (8.8876) % which means that it has lost $8.8876 on every $100 spent on assets. This is way below average. Pathfinder Cell's management efficiency ratios could be used to measure how well Pathfinder Cell manages its routine affairs as well as how well it operates its assets and liabilities.Pathfinder Cell Workforce Comparison
Pathfinder Cell Therapy is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,116. Pathfinder Cell adds roughly 1.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Pathfinder Cell Therapy Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pathfinder Cell Therapy Price Series Summation is a cross summation of Pathfinder Cell price series and its benchmark/peer.
Pathfinder Cell Notable Stakeholders
A Pathfinder Cell stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pathfinder Cell often face trade-offs trying to please all of them. Pathfinder Cell's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pathfinder Cell's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Richard Franklin | President CEO, Secretary, Director | Profile | |
Joerg Gruber | Founder and Chairman | Profile | |
John Benson | CFO and Treasurer | Profile |
About Pathfinder Cell Management Performance
The success or failure of an entity such as Pathfinder Cell Therapy often depends on how effective the management is. Pathfinder Cell management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pathfinder management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pathfinder management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. PATHFINDER CELL operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 1 people.
Please note, the presentation of Pathfinder Cell's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pathfinder Cell's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pathfinder Cell's management manipulating its earnings.
Pathfinder Cell Workforce Analysis
Traditionally, organizations such as Pathfinder Cell use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pathfinder Cell within its industry.Pathfinder Cell Manpower Efficiency
Return on Pathfinder Cell Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.4M | |
Net Loss Per Executive | 464.7K |
Complementary Tools for Pathfinder Pink Sheet analysis
When running Pathfinder Cell's price analysis, check to measure Pathfinder Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pathfinder Cell is operating at the current time. Most of Pathfinder Cell's value examination focuses on studying past and present price action to predict the probability of Pathfinder Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pathfinder Cell's price. Additionally, you may evaluate how the addition of Pathfinder Cell to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Transaction History View history of all your transactions and understand their impact on performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |